Prot #GS-US-395-1663: A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Crohn's Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date2/26/162/26/19

Funding

  • Gilead Sciences, Inc. (Prot #GS-US-395-1663)